Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 14/20 | 0.95 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.95 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.95 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid Monododecyl Ester SCHEMBL118202 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| Hexadecyl Dihydrogen Phosphate SCHEMBL61625 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL118083 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL8340226 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL4280475 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL3409562 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL28337300 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL3411900 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL3256566 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL11137451 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 819 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119797926-A | High-solid-phase-content slurry for silicon carbide workpiece and preparation method thereof | 杭州蓝碳新材料有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118270947-A | Photovoltaic fluorine-containing wastewater multistage treatment method based on semipermeable membrane separation and semipermeable membrane thereof | 无锡市道格环保科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-113768869-B | Propranolol hydrochloride microemulsion gel and preparation method and application thereof | 华中药业股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-115887294-B | Selenium disulfide shampoo and preparation method thereof | 诺斯贝尔化妆品股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118078729-A | Cleansing cream with moisturizing and skin care effects and preparation method thereof | 醇度国际生物科技(北京)有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117904632-A | Semiconductor titanium etching solution, and preparation method and application thereof | 浙江奥首材料科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117838565-A | Cleansing face cleansing gel and preparation method thereof | 诺斯贝尔化妆品股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117717748-A | Three-phase water film-forming foam extinguishing agent, and preparation method and application thereof | 中国科学技术大学 | 2024-03-19 | — | — | CN | claimed |
| CN-117585718-A | Method for recycling vanadium pentoxide in vanadium electrolyte | 四川星明能源环保科技有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117546868-A | Method for preparing fragrant disinfectant | 南昌大学 | 2024-02-13 | — | — | CN | claimed |
| EP-2234675-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | Schering-Plough Healthcare Products, Inc. (US) | 2010-10-06 | — | — | EP | claimed |
| WO-2009079486-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 2009-06-25 | — | — | WO | claimed |
| US-20090155194-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. | 2009-06-18 | — | — | US | claimed |
| EP-2066283-A1 | DELIVERY OF AN ODOR CONTROL AGENT THROUGH THE USE OF A PREMOISTENED WIPE | Kimberly-Clark Worldwide, Inc. (US) | 2009-06-10 | — | — | EP | claimed |
| EP-2046930-A2 | RHAMNOLIPID-BASED FORMULATIONS | Aurora Advance Beauty Labs. (US) | 2009-04-15 | — | — | EP | claimed |
| US-20080213194-A1 | A cleaning formulation of 0.01-99.9% of rhamnolipid and carrier; antiseptics; deodorants; microbiocides; fungicides; biofilms; biosurfactants; animal cleaning; wound healing agents; personal care; cleaning surfaces of households, food preparation; toys, medical equipment; protective coatings; nontoxic | AURORA ADVANCED BEAUTY LABS | 2008-09-04 | — | — | US | claimed |
| WO-2008075233-A1 | DELIVERY OF AN ODOR CONTROL AGENT THROUGH THE USE OF A PREMOISTENED WIPE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2008-06-26 | — | — | WO | claimed |
| US-20080145267-A1 | Delivery of an odor control agent through the use of a presaturated wipe | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-06-19 | — | — | US | claimed |
| WO-2008013899-A2 | RHAMNOLIPID-BASED FORMULATIONS | AURORA ADVANCE BEAUTY LABS (US) | 2008-01-31 | — | — | WO | claimed |
| CN-1730390-A | Process for preparing monox mesoporous material with helical structure | UNIV SHANGHAI JIAOTONG (CN) | 2006-02-08 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155194-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | TYR, AP2S1, POLL | LPAR3 4113/4885LPAR2 4159/4885LPAR1 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.